In late January, CARsgen Therapeutics, a biopharmaceutical company with operations in China and the U.S., started moving employees into a biomanufacturing facility in Durham, N.C., the company’s first such operations in North America.
CARsgen has clinical offices in Houston, and its holding company was founded in Shanghai in 2014. It is investing $157 million for the North Carolina campus, which is expected to eventually house 200 workers by 2026. That campus is being developed in two phases: the first (which opened officially on February 21) is a 37,000-sf research and development lab for early-stage manufacturing of chimeric antigen receptor T-cell (CAR-T) therapies that battle cancers. Upon FDA approval of those therapies, CARsgen will start construction on a 100,000-sf cGMP commercial manufacturing plant.
Jie Jia, PhD, CARsgen’s Vice President of Strategic Alliances and Operations, is hopeful that the factory can be started by late 2022.
This project is but the latest example of demand-driven construction of lab space. The Raleigh-Durham market is a hot bed for companies developing CAR-T therapies that use patient-derived T cells that are customized in the manufacturing process for each patient.
Jie tells BD+C that his company selected North Carolina’s Research Triangle for its campus because of its “local ecosystem” that, according to the North Carolina Biotechnology Center’s website, includes three comprehensive cancer centers—UNC Lineberger, Duke Cancer Institute, and Wake Forest Baptist Health—as well as the NC Rare Disease Network and the North Carolina Precision Health Collaborative.
CARsgen reportedly considered locating its facility in Maryland, which offered $35 million in incentives, but ultimately chose North Carolina, which offered a $2.2 million grant and tax reimbursement package over 12 years, according to the state’s Economic Development Partnership, which with NCBioTech and North Carolina’s Department of Commerce recruited the company.
Helping CARsgen with site selection was CRB, an AEC and consulting firm that specializes in life sciences projects. It has been working with CARsgen since late 2020 to develop the entire program in North Carolina. CRB is providing engineering, design, and construction services as part of a building team that includes EAS (prefabrication), Star Electric (electrical), Edwards Inc. (structural, demolition, and concrete), and Dagard (which provided the lab’s cleanroom wall and ceiling panel systems).
LAB FACILITY IS LIKE BUILDING AN OREO COOKIE IN REVERSE
The R&D facility is an adaptive reuse of what had been an office and warehouse built in the early 1990s. CARsgen singled out this building over several others it and CRB looked at, explains Jie, because “it could be transformed quickly.” But that didn’t necessarily mean easily.
The first building took 13 months from conception to occupancy, and construction started in July 2021, says Ryan Lowder, DBIA, Project Director for CRB. The design team considered 15 different floor plans, as CARsgen at first preferred a smaller facility. “It realized that its plans needed to expand to accommodate the number of patients it would be creating drugs for,” Lowder explains.
The project’s biggest challenge, says A.L. Nesbitt, CRB’s Project Management Group Lead, was getting the floors to the height needed for HVAC systems the cleanroom required. This single-story building had an interior ceiling height of 18 feet, “which wasn’t optimal,” laments Lowder. The headroom space for the lab’s cleanroom is a tight nine feet, six inches, says Nesbitt.
In addition, the building team had to refortify the building’s floor slab—which over the years had been cut up into pieces for multiple tenants—to support new equipment plus dead loads like ductwork.
In adapting the building, CRB deployed its ONEsolution integrated project delivery (IPD) approach. Lowder elaborates that the building used a “self-supporting” modular cleanroom system, so that everything else in the lab could be installed first to meet timelines and the space available. “It was like building an Oreo cookie in reverse,” he quips. Abetting this approach was offsite manufacturing, by EAS, of ductwork, pipe racks, and other components that were assembled into five large sections and then transported to the jobsite for installation.
Nesbitt observes that developers of offices and labs are scrambling to get into cleanroom construction. CRB, which already had the expertise, was “lucky” to be working with CARsgen, “that was willing to be innovative,” she says. Jie adds that his company is receptive to adaptive reuse for future expansion. But supply chain snags for materials pose dilemmas. “So we have to get into projects earlier,” he says. That’s especially true for a biopharm company whose business model success hinges on speed to market.
Related Stories
University Buildings | Feb 21, 2024
University design to help meet the demand for health professionals
Virginia Commonwealth University is a Page client, and the Dean of the College of Health Professions took time to talk about a pressing healthcare industry need that schools—and architects—can help address.
Urban Planning | Feb 5, 2024
Lessons learned from 70 years of building cities
As Sasaki looks back on 70 years of practice, we’re also looking to the future of cities. While we can’t predict what will be, we do know the needs of cities are as diverse as their scale, climate, economy, governance, and culture.
Laboratories | Feb 5, 2024
DOE selects design-build team for laboratory focused on clean energy innovation
JE Dunn Construction and SmithGroup will construct the 127,000-sf Energy Materials and Processing at Scale (EMAPS) clean energy laboratory in Colorado to create a direct path from lab-scale innovations to pilot-scale production.
Laboratories | Jan 25, 2024
Tactical issues for renovating university research buildings
Matthew Plecity, AIA, ASLA, Principal, GBBN, highlights the connection between the built environment and laboratory research, and weighs the benefits of renovation vs. new construction.
Laboratories | Jan 22, 2024
Speculative vs purpose-built labs: Pros and cons
Hanbury's George L. Kemper, AIA and R. David Cole, AIA share the unique advantages and challenges of both spec. and purpose-build labs.
University Buildings | Jan 18, 2024
Houston’s Rice University opens the largest research facility on its core campus
Designed by Skidmore, Owings & Merrill (SOM), the 251,400-sf building provides students and researchers with state-of-the-art laboratories, classrooms, offices, and a cafe, in addition to multiple gathering spaces.
Healthcare Facilities | Jan 7, 2024
Two new projects could be economic catalysts for a central New Jersey city
A Cancer Center and Innovation district are under construction and expected to start opening in 2025 in New Brunswick.
Laboratories | Jan 5, 2024
Office conversions are helping to meet the growing demand for life-science space
Ware Malcomb and Rock Creek Property Group led the team that recently completed the adaptive reuse of two office buildings in Maryland.
Mass Timber | Jan 2, 2024
5 ways mass timber will reshape the design of life sciences facilities
Here are five reasons why it has become increasingly evident that mass timber is ready to shape the future of laboratory spaces.
Giants 400 | Nov 28, 2023
Top 55 Laboratory Construction Firms for 2023
Whiting-Turner, DPR Construction, STO Building Group, Skanska, and Hensel Phelps top BD+C's ranking of the nation's largest laboratory general contractors and construction management (CM) firms for 2023, as reported in Building Design+Construction's 2023 Giants 400 Report.